Literature DB >> 19508128

Use of human amnion epithelial cells as a feeder layer to support undifferentiated growth of mouse embryonic stem cells.

Dongmei Lai1, Weiwei Cheng, Tianjin Liu, Lizheng Jiang, Qin Huang, Te Liu.   

Abstract

Mouse and human embryonic stem (ES) cells are usually maintained in an undifferentiated state by coculture with mouse embryonic fibroblasts (MEFs) as feeder cells. In the case of mouse ES cells, addition of leukemia inhibitory factor (LIF) to culture media is also necessary to prevent cell differentiation. Here, we report the use of primary human amnion epithelial cells (hAECs) as feeder cells to culture mouse ES cells using our newly developed protocols. We found that mouse ES cells grown on hAECs express ES cell markers including FGF, Oct-4, Nanog, Sox-2, Rex, and TERT. Interestingly, the expression levels of these genes are three- to five fold higher on hAECs than on MEFs by quantitative real-time PCR. The quicker growing ES cells on hAECs showed a normal 19XY karyotype on passages 25, and ruled out the transformation of ES cells. Using flow cytometry analysis, we show that ES cells grown on hAECs have the same cell cycle distribution pattern as those on MEFs. Further, mouse ES cells cultured on hAECs for at least 20 passages retain the capability of teratoma formation in mice. Finally, we reveal that hAECs express highly LIF that allows for ES growth without the need of addition of commercially obtained LIF. Taken together, our data suggest that hAECs are suitable for mouse ES cell culture and may prove to be a useful alternative to MEFs for human ES cell culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508128     DOI: 10.1089/clo.2008.0047

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  8 in total

1.  Human amniotic epithelial cells maintain mouse spermatogonial stem cells in an undifferentiated state due to high leukemia inhibitor factor (LIF) expression.

Authors:  Te Liu; Lihe Guo; Zhixue Liu; Weiwei Cheng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-03-18       Impact factor: 2.416

2.  Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

Authors:  Te Liu; Fuhui Xu; Xiling Du; Dongmei Lai; Tianjin Liu; Yarui Zhao; Qin Huang; Lizhen Jiang; Wenbin Huang; Weiwei Cheng; Zhixue Liu
Journal:  Mol Cell Biochem       Date:  2010-03-12       Impact factor: 3.396

3.  KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.

Authors:  Z Dong; L Yang; D Lai
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

Review 4.  Amnion-derived stem cells: in quest of clinical applications.

Authors:  Toshio Miki
Journal:  Stem Cell Res Ther       Date:  2011-05-19       Impact factor: 6.832

5.  Derivation and characterization of human embryonic stem cells on human amnion epithelial cells.

Authors:  Dongmei Lai; Yongwei Wang; Jian Sun; Yifei Chen; Ting Li; Yi Wu; Lihe Guo; Chunsheng Wei
Journal:  Sci Rep       Date:  2015-05-07       Impact factor: 4.379

6.  Human foreskin fibroblast produces interleukin-6 to support derivation and self-renewal of mouse embryonic stem cells.

Authors:  Yu Ma; Junjie Gu; Chunliang Li; Xiaoyuan Wei; Fan Tang; Guilai Shi; Jing Jiang; Ying Kuang; Jinsong Li; Zhugang Wang; Xin Xie; Ying Jin
Journal:  Stem Cell Res Ther       Date:  2012-07-31       Impact factor: 6.832

7.  Human amniotic epithelial cell feeder layers maintain iPS cell pluripotency by inhibiting endogenous DNA methyltransferase 1.

Authors:  Qing Chen; Chaolin Qiu; Yongyi Huang; Lizhen Jiang; Qin Huang; Lihe Guo; Te Liu
Journal:  Exp Ther Med       Date:  2013-09-02       Impact factor: 2.447

8.  The enzymatic de-epithelialization technique determines denuded amniotic membrane integrity and viability of harvested epithelial cells.

Authors:  Peter Trosan; Ingrida Smeringaiova; Kristyna Brejchova; Jan Bednar; Oldrich Benada; Olga Kofronova; Katerina Jirsova
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.